Pmda - Pharmaceuticals and Medical Devices Agency
Menu
Close

Regulatory Science/The Science Board/Standard Development

The 3rd Subcommittee on Therapeutic Products Based on Extracellular Vesicles (EVs) Including Exosomes

Press Release

January 17, 2022 from 2pm to 4:25pm
Given the impact of COVID-19, the conference was held online.

Agenda / List of Handouts

Agenda
  1. Lecture on Therapeutic Products Based on Extracellular Vesicles (EVs) Including Exosomes and Discussion
    • Current Status and Future Prospects of New Drug Development Based on Exosomes
       (Specially Appointed Professor SAWA Yoshiki of Graduate School of Medicine,
       Osaka University)
  2. Prewriting the Assigned Parts to Members
  3. Others
 
List of Handouts
  • Document 1 Lecture Material by Specially Appointed Professor SAWA
  • Document 2 Summary of Discussions at the 1st Working Group
  • Document 3 Lecture Material by Professor TAKAKURA (Chairperson of the Subcommittee)
  • Document 4 Draft Report (Integrated Version)